Status:
UNKNOWN
Effect of Hyperuricaemia on Chronic Renal Disease
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Collaborating Sponsors:
The First People's Hospital of Xuzhou
Conditions:
Hyperuricemia
Chronic Renal Disease
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
To investigate the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention
Detailed Description
This study aims to explore the best effective dose and adverse reaction of febuxostat in lowering serum uric acid to low level in patients with Chronic Renal Disease at different stages. To elucidate ...
Eligibility Criteria
Inclusion
- Non-dialysis CKD patients with serum uric acid greater than 7mg/dl.
- eGFR≥15ml/min/1.73m².
- Low salt, low protein, low purine diet.
Exclusion
- Take drugs that raise blood uric acid at the same time.
- Patients with gout attacks.
- Patients with pregnant, lactating.
- Autosomal dominant polycystic kidney disease.
- Patients with poor general condition and multiple organ failure.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03425708
Start Date
January 1 2017
End Date
December 31 2018
Last Update
February 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China, 221000